investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Role of p21 Activated Kinase in Leukemogenesis

Reuben Kapur

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Xin Wang

Dana-Farber Cancer Institute

Boston, United States

University of Manchester

Manchester, United Kingdom

Related projects

Jeffrey S Miller

NK Cells, their Receptors and Unrelated Donor Transplant

Leukaemia

Hematology and hematologic malignancies

Elizaveta V Benevolenskaya

RBP2 Regulation Through Differential Recruitment to Genomic Loci

Leukaemia

Hematology and hematologic malignancies

H Leighton Grimes

Developing Novel STAT5 Protein Inhibitors for Treatment of Leukemias

Leukaemia

Hematology and hematologic malignancies

Edward W Harhaj

Mechanisms of HTLV-I Tax Mediated NF-kB Activation

Leukaemia

Hematology and hematologic malignancies

Tait D Shanafelt

Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies

Richard E Champlin

The Therapy of Chronic Myeloid Leukemia (CML)

Leukaemia

Hematology and hematologic malignancies

David A Fruman

TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance

Leukaemia

Hematology and hematologic malignancies

Richard A Flavell

Understanding Hemotopoietic Neoplasias using Humanized Mice

Leukaemia

Hematology and hematologic malignancies

Richard J Jones

Bone Marrow Transplantation in Human Disease

Leukaemia

Hematology and hematologic malignancies